Easy Access IP
A new way to share our intellectual property
We recently released a new portfolio of innovative technologies and opportunities available to license for free under Easy Access Intellectual Property (IP) – a new initiative to make it easier for you to obtain more of our IP and put it to use.
We recognise that it can sometimes be too early - or the market too uncertain - to invest in real-world applications of particular intellectual property. It’s this particular IP that we want you to license for free, enabling you to explore the possibilities with reduced risk.
We make it easy by:
-
Offering a range of IP to license for free in our Easy Access portfolio
-
Using quick, simple, 1-page agreements: no lengthy or costly negotiations
Easy Access IP is a first for the sector and King’s is one of three universities pioneering this new way to get our IP into your hands.
To read our full press release, please
click here.
Why so easy?
King’s is an open-innovation university and we work collaboratively with a wide range of organisations in mutually beneficial partnerships. What’s most important to us as a university is to see our knowledge and expertise adopted for the benefit of our economy or society. Making it easy to access more of our IP is one way we can maximise the amount of King’s knowledge and expertise that is exploited for public benefit.
Easy Access IP provides a new, flexible way of working with us.
To view our first batch of Easy Access opportunities, please follow the links below.
Our extensive research base provides a broad portfolio of novel technologies and opportunities in healthcare (including diagnostics, therapeutics and medical devices), IT and engineering that are available for licensing, so if you don’t find an Easy Access IP technology that appeals to you, please get in touch with one of our specialists to find out about other opportunities:
Fauzia Farooq
Melissa Rubock
Michael Jorgensen
Francesca Gliubich
Current opportunities in our Easy Access portfolio:
Assay for investigating nonsense mutations
Highthroughput assay system for rapid whole mammalian cell analysis which provides information about the impact of nonsense mutations on protein translation and identify factors that modulate translation readthrough.
Preventing cavities the SMART way
A topical gel that can be placed around the teeth to prevent infection with Streptococcus mutans; the main cause of dental cavities.
Metamorphic Robotic Palm
A novel robotic palm mechanism which allows added functionality with both complex and precise movements in the same device.
Rapid in vitro screen for compounds aimed at genetic risk factors in Alzheimer’s
Researchers at the Institute of Psychiatry, King’s College London, have identified a novel evolutionarily conserved protein that interacts with APP, as shown in independent genetic, biochemical and cellular assays on the mouse, human and Drosophila orthologues.
Alternatively, you can find more technologies available to license here
Easy Access licence agreements
If you are interested in pursuing any of our Easy Access IP portfolio opportunities, read through our simple 1-page licence agreements below:
Exclusive licence agreement
Non-exclusive licence agreement
For more information about Easy Access IP at King’s, please contact Dr Mike Shaw.
About the Easy Access Innovation partnership
King’s is a co-founding partner of Easy Access Innovation, together with the Universities of Glasgow and Bristol. To find out which technologies are being offered as Easy Access IP by our partners follow the links below:
University of Glasgow’s opportunities
University of Bristol’s opportunities
Easy Access Innovation is open to other UK and international universities to join. Read more about the initiative and how you can join.